A sale could value Amoun at $700 million to $800 million, Bloomberg reported. (http://bloom.bg/1EXe5PQ)
Valeant in talks to buy Egyptian drugmaker Amoun Pharma: Bloomberg
(Reuters) - Valeant Pharmaceuticals International Inc is in talks to buy Egyptian drugmaker Amoun Pharmaceutical Co to expand its veterinary and human medicines portfolio, Bloomberg reported, citing people familiar with the matter.
Valeant was not immediately available for comment.
Should Amoun fail to find a buyer, it may consider an initial public offering in London, the report said.
Amoun could not be immediately reached for comment.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
FG to review recent price hike of DStv, GOtv packages amid public outcry
BREAKING: FG grants Air Peace right to commence Abuja-London flights - Keyamo
Deputy who dumped Akeredolu clinches PDP governorship ticket
Gov inaugurates 2nd phase of palliative distribution to poor Enugu residents
Flight Dispatchers fault Keyamo's order to suspend Dana Air over landing mishap
Respite for Nigerians as NNPC says cause of fuel scarcity has been resolved
Again, JAMB extends Direct Entry registration, says 2024 UTME best in history
Lagos residents need real empowerment, not your food packs, LP tells Sanwo-Olu
Ikoyi prison controller in trouble for disobeying court order on convict's whereabouts
ADVERTISEMENT